Detalhe da pesquisa
1.
Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome.
Brain
; 144(2): 682-693, 2021 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33313649
2.
Phase II study of the histone deacetylase inhibitor vorinostat (Suberoylanilide Hydroxamic Acid; SAHA) in recurrent or metastatic transitional cell carcinoma of the urothelium - an NCI-CTEP sponsored: California Cancer Consortium trial, NCI 6879.
Invest New Drugs
; 39(3): 812-820, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33409898
3.
Emergency presentations of movement disorders.
Pract Neurol
; 20(4)2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32299832
4.
Reversible cerebral vasoconstriction syndrome secondary to caffeine withdrawal.
Scott Med J
; 63(1): 22-24, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28480791
5.
The World I Fell Out Of by Melanie Reid.
Pract Neurol
; 20(6): 516, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32546516
6.
Neurological Scottish neologisms.
Pract Neurol
; 19(6): 465-466, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31611419
7.
A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: a California Cancer Consortium Study.
Br J Haematol
; 180(3): 445-448, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27650362
8.
Order of patient entry and outcomes in phase II clinical trials: A meta-analysis of individual patient data.
Contemp Clin Trials
; 125: 107083, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36638911
9.
Pharmacological Interventions for Sialorrhoea in People with Parkinson's Disease: A Systematic Review and Meta-Analysis.
Mov Disord Clin Pract
; 10(4): 558-568, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37070045
10.
A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors.
Cancer Chemother Pharmacol
; 87(4): 525-532, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33423090
11.
Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878).
Clin Lung Cancer
; 22(6): 541-548, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34140248
12.
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 7(10): 1536-1543, 2021 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34436521
13.
Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients With Advanced NSCLC (NCI 10327): Rationale and Study Design.
Clin Lung Cancer
; 22(1): 67-70, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33229301
14.
Untenable dosing: A common pitfall of modern DLT-targeting Phase I designs in oncology.
Curr Probl Cancer
; 44(6): 100583, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32446637
15.
Model of a Queuing Approach for Patient Accrual in Phase 1 Oncology Studies.
JAMA Netw Open
; 3(5): e204787, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32401317
16.
Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies.
Leuk Lymphoma
; 61(2): 309-317, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31617432
17.
Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma.
Clin Cancer Res
; 26(5): 1034-1044, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31811017
18.
Intravenous 5-fluoro-2'-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 85(5): 979-993, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32314030
19.
Geographical difference in Parkinson's disease prevalence within West Scotland.
Mov Disord
; 24(3): 401-6, 2009 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19021227
20.
Accuracy of Parkinson's disease diagnosis in 610 general practice patients in the West of Scotland.
Mov Disord
; 24(16): 2379-85, 2009 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19890985